# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5032022 | B | Binding affinity to SARS-CoV-2 spike protein receptor-binding domain by biolayer interferometry (BLI) assay | Severe acute respiratory syndrome coronavirus 2 | 3 | single protein format | Scientific Literature | ||
2. | ALA5032023 | A | Stability of the compound in proteinase K (unknown origin) in presence of serum assessed as loss of peptide measured after 2.5 hr | Not specified | 2 | assay format | Scientific Literature | ||
3. | ALA5032024 | F | Antiviral activity against SARS-CoV-2 assessed as neutralization viral infection in Vero cells by measuring cytopathic effect incubated for 4 days by crystal violet staining based assay | Severe acute respiratory syndrome coronavirus 2 | 2 | organism-based format | Scientific Literature | ||
4. | ALA5032025 | A | Cytotoxicity against African green monkey Vero cells assessed as viable cells measured by MTS assay | Chlorocebus sabaeus | 2 | cell-based format | Scientific Literature | ||
5. | ALA5032026 | F | Antiviral activity against SARS-CoV-2 B.1.1.7 variant assessed as neutralization viral infection in Vero cells by measuring cytopathic effect incubated for 4 days by crystal violet staining based assay | Severe acute respiratory syndrome coronavirus 2 | 2 | organism-based format | Scientific Literature | ||
6. | ALA5032027 | F | Antiviral activity against SARS-CoV-2 B.1.351 variant assessed as neutralization viral infection in Vero cells by measuring cytopathic effect incubated for 4 days by crystal violet staining based assay | Severe acute respiratory syndrome coronavirus 2 | 2 | organism-based format | Scientific Literature |